Desenvolvimento de lipossomas híbridos contendo fragmentos de membranas de células tumorais para imunoestimulação na terapia antitumoral

Detalhes bibliográficos
Ano de defesa: 2019
Autor(a) principal: Gonçalves, Marcilia Viana Pavam lattes
Orientador(a): Lima, Eliana Martins lattes
Banca de defesa: Lima, Eliana Martins, Silva, Lorena Maione, Nascimento, Thais Leite, Souza, Ana Luiza Ribeiro de
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Goiás
Programa de Pós-Graduação: Programa de Pós-graduação em Ciências Farmacêuticas (FF)
Departamento: Faculdade Farmácia - FF (RG)
País: Brasil
Palavras-chave em Português:
Área do conhecimento CNPq:
Link de acesso: http://repositorio.bc.ufg.br/tede/handle/tede/10225
Resumo: A lot of progress has been made in the past decades in the development of nanoparticles as carriers of antitumor drugs, and today, with the successes achieved with cancer immunotherapy, many advances have been made with the use of nanoparticles to arouse effective immune response against tumor cells. In this study, hybrid synthetic phospholipids associated to phospholipids and cell membrane proteins from B16F10 cells were developed. Through the microfluidization technique hybrid liposomes of 130 µm average diameter were obtained. Thus, by studying the membrane fluidity and mobility, the interaction between the phospholipids could be confirmed by the Electron Paramagnetic Resonance (EPR) technique. Finally, a model of murine cutaneous melanoma was standardized from the inoculation of cells of tumor line B16F10, the same ones used to obtain hybrid liposomes, in order to pave the way for future studies on the in vivo immune response.